By National Eczema Association
Published On: Jun 24, 2019
Last Updated On: Jul 13, 2021
Since awarding our first grant in 2004, the National Eczema Association has funded research to improve the health and quality of life for people with all forms of eczema. As the largest private nonprofit funder of eczema research, we have invested over $1.1 million to date.
To put things into perspective, for every $1 NEA has invested in eczema research, our grantees have collectively gone on to obtain an additional $12.13 in subsequent National Institutes of Health (NIH) funding to support further research.
NEA funds research for both adult eczema and pediatric eczema guided by the following five research priorities, which were established by our Scientific Advisory Committee:
- Cutting Edge Basic & Translational Science – Innovative investigations of targets, pathways, or technologies that will advance understanding of the pathophysiology or natural history of eczema, and potentially lead to new or enhanced therapies.
- Eczema Heterogeneity: Novel Insights – Projects aimed at advancing the understanding of the underlying factors contributing to the diversity of eczema, treatment response and comorbidities.
- Innovations in Clinical Practice & Care – Studies addressing approaches to facilitate optimal identification and treatment of eczema and associated comorbidities in all health care settings to enhance patient-reported and patient-centric outcomes.
- Understanding & Alleviating Disease Burden – Insightful proposals that identify, quantify or aim to reduce aspects of eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic/occupational, or economic impacts) based on patient population, treatment approach, etc.
- Eczema Prevention – Novel investigations into the potential risk factors and strategies of primary eczema prevention at all ages.
“We are working hard to increase the number of scientists, research projects and research dollars devoted to eczema, which may lead to better therapies, better care, better outcomes—and hopefully, one day—a cure,” said NEA Director of Research Wendy Smith Begolka.
Attention, researchers: the 2019 grant cycle is open!